Carmot Therapeutics
Biotechnology
Carmot Therapeutics valuation and funding history | Last updated: May 25, 2023 | 2 funding rounds
Current Valuation
N/A
As of May 25, 2023
Total Funding Raised
N/A
Across 2 rounds
Last Round
Later Stage VC (Series E)
$150.0M
Last Funding
May 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| May 25, 2023 | Later Stage VC (Series E) | $150.0M | N/A | - |
| July 25, 2022 | Later Stage VC (Series D) | $160.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Carmot Therapeutics is currently valued at N/A as of May 25, 2023.
What is Carmot Therapeutics Worth in 2026?
Carmot Therapeutics is a leading private company in the Biotechnology sector. Track Carmot Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Carmot Therapeutics Valuation is Determined
Private company valuations like Carmot Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.